Dr. Glicksman is the Chief Scientific Officer at ORIG3N. ORIG3N offers a broad range of affordable DNA tests that help people learn more about their genes, and the role they play in their bodies and their lives. Dr. Glicksman received a bachelor’s degree from Brown University and a Ph.D. degree in Neuroscience from Washington University. Dr. Glicksman has over 75 publications and 12 issued patents. Dr. Glicksman has been in the field of drug discovery for more than 20 years. She worked in the biopharmaceutical industry for 13 years and then was on the faculty of Harvard Medical School and Brigham and Women’s Hospital and Co-Directed the Laboratory for Drug Discovery in Neurodegeneration (LDDN). She is on the science advisory board for the Alzheimer’s Drug Discovery Foundation (ADDF) and the California Institute for Regenerative Medicine (CIRM), and reviews grants for NIH, Department of Defense, SBIR, the Michael J Fox Foundation, Alzheimer’s Association, and Rett Foundation.
